D. Olga McDaniel, PhD
Position: Associate Professor, Division of General Surgery
Office Phone: 601-984-5081
Office Fax: 601-984-6614
E-mail: omcdaniel@surgery.umsmed.edu
Research Interests: Immunogenetic Studies in Renal and Heart Transplantation, Neurodegenerative Disorders and Trauma Induced Complications, Nucleic Acid Sequencing, Single Nucleotide Polymorphism (SNP), and Gene Expression Analysis.
Societies: American College of Rheumatology- 1985, American Society of Histocompatibility and Immunogenetics - 1988, American Society of Microbiology - 1980, The American Society of Human Genetics- 2001, Federation of Clinical Immunology Societies - 2001, Mississippi Academy of Sciences - 1998
Bibliography:
1. Murphy, J.W., McDaniel, D.O. In vitro reactivity of natural killer (NK)cells against Cryptococcus neoformans. J. Immunol. 1982; 128(4):1577-1583.
2. McDaniel, D.O., Reveille, J.D. , Barger, B.O., Acton, R.T. Associationof restriction fragment length polymorphism with seronegative spondyloarthropathies.Biochemical Transactions 1985; 14:85-86.
3. Acton, R.T., Hodge, T.W., McDaniel, D.O., Reveille, J.D. Napier-Littrell,M., and Barger, B.O. HLA restriction fragment length polymorphisms associatedwith Insulin dependent diabetes mellitus and the seronegative spondyloarthropathies.Bioscience Reports. 1985; 5:815-829.
4. McDaniel, D.O., Acton R.T., Barger, B.O., Koopman, W.J., and Reveille,J.D. Association of a 9.2 Kb PvuII MHC Class I restriction length polymorphismwith ankylosing spondylitis. Arthritis Rheum. 1987; 30:894-900.
5. Napier-Littrell, M., Acton, R.T., McDaniel, D.O., Hodge, T.W. and Barger,B.O. Association of restriction fragment length polymorphisms with MHC ClassII phenotypes in white and black individuals. Transplantation Proc. 1987;19(1):826-832.
6. Acton, R.T., Barger, B.O., Brennan, J., Chandler, J., Cousins, L., Go,R., Gore, T., McDaniel, D.O., Moore, P., Olsen, G., Simpson, M., Vanichanan,C., Wagenkenecht, L., and Copeland, R. Immunogenetic and genetic risk indicationsof early-onset coronary heart disease. Federation Proc 1988; 47:1652
7. McDaniel, D.O., Barger, B.O.,., Koopman, W.J., Acton R.T., and Alarcón,G.S. Molecular genetic studies of rheumatoid arthritis. Amer J Med 1988; 85:23-25.
8. Reveille, J.D., Koopman, W.J., Barger, B.O., Acton, R.T. and McDaneil,D.O. Restriction fragment length polymorphism analysis in ankylosing spondylitis.Amer J Med 1988; 85:48-50.
9. McDaniel, D.O., Barger, B.O.,., Koopman, W.J., Acton R.T., and Reveille,J.D. AS and a 9.2 Kb PvuII Class I HLA DNA restriction fragment . J Rheumatol.1989; 14:145-146.
10. Acton, R.T., Hodge, T.W., Go, R.C.P., Peiper, S.C., Barger, B.O., Harman,L., and McDaniel, D.O. A stratified approach to forensic identification byDNA analysis of genes within the major histocompatibility complex (MHC). FBIPublications, 1989.
11. McDaniel, D.O., Acton R.T., Barger, B.O., Koopman, W.J., and Alarcón,G.S. Molecular analysis of HLA-D region genes in seropositive rheumatoid arthritis.Tissue Antigens 1989; 34:299-308.
12. Yang, P.M., Crowley, J.J., McDaneil, D.O., Koopman, W.J., Kozin, F., Carson,D.A., and Chen, P.P. Genetic studies of four highly homologous rheumatoidfactor-associated Vk genes, in rheumatoid arthritis patients and normal individuals.Mol Immunol 1991; 28(10):1073-1083.
13. Perry, R., Go, R.C.P., Harrell, L., McDaniel, D.O., Vanichanan, C., Foster,L.J., and Acton, R.T. PCR-RFLP and SSCP analyses of the APP and PRNP genesin early-onset of Alzheimer disease patients. Proceedings of The GreenwoodCenter 1992; Vol 11:178.
14. McDaniel, D.O., Naftilan, J., Barber W.H. Limiting detection of an amplificationsignal for HLA-D region and VNTR genes by 32P-PCR. Biotechniques. 1993; 15:140-145.
15. McDaniel, D.O., Naftilan. J., Hulvey, K., Shaneyfelt, D., Lemons J.A.,Lagoo-Deenadayalan, S., Hudson, S., Diethelm, A.G., Barber, W.H. Peripheralblood chimerism in renal allograft recipients transfused with donor bone marrow.Transplantation. 1994; 57:852-856.
16. Reveille, J.D., Suarez-Almazor, M.E., Russell, A.S., Go, R.C.P., Appleyard,J., Barger, B.O., Acton, R.T., Koopman, W.J., McDaniel, D.O. HLA in Ankylosingspondylitis. Is HLA-B27 the only MHC gene involved in disease pathogenesis.Sem Arthritis Rheum, 1994; 295-309.
17. McDaniel, L.S., Ralph, B.A., McDaniel, D.O., Briles, D.E. Localizationof protection eliciting epitopes on PspA of Streptococcus pneumoniae betweenamino acid residues 192 and 260. Microbial Pathogenesis. 1994; 17:323-337.
18. Lagoo-Deenadayalan, S., Lagoo, A.S., Lemons, J.A., Lorenz, H.M., McDaniel,D.O., Hardy, K.J., Barber, W.H. Donor specific bone marrow cells suppresslymphocyte reactivity to donor antigens and differentially modulate Th1 andTh2 cytokine gene expression in the responder cell population. TransplantImmunology, 1995; 3:108-118.
19. McDaniel, D.O., Alarcón, G.S., Pratt, P.W., Reveille, J.D. Most African-AmericanPatients with Rheumatoid Arthritis do not have the Rheumatoid Antigenic determinant(Epitope). Ann Intern Med. 1995; 123:181-187.
20. Lagoo-Deenadayalan, S., Lagoo, A.S., Lemons, J.A., Lorenz, H.M., McDaniel,D.O., Hardy, K.J., Barber, W.H. Donor specific bone marrow cells suppresslymphocyte reactivity to donor antigens and differentially modulate Th1 andTh2 cytokine gene expression in the responder cell population. Advances inNephrology. 1996; 25:107-127.
21. Salhudeen, A., Wang, C., McDaniel, D.O., Lagoo, S.D., Bigler, S., Barber,W.H. Antioxidant Lazaroid U-74006F improves renal function and reduces theexpression of cytokines, iNOS, and MHC antigens in a syngeneic renal transplantmodel. Transplantaiton 1996; 62:1628-1633.
22. Vig, P.J.S., Subramony, S.H., Burright, E.N., Fratkin, J.D., McDaniel,D.O., Desaia, D., Qin, Z. Reduced immunoreactivity to Ca binding proteinsin Purkinje cells proceeds onset of ataxia in spinocerebellar ataxia 1 (SCA-1)transgenic mice. Neurology, 1998; 50:106-113.
23. McDaniel, L.S., McDaniel, D.O., Hollingshead, S.K., Briles, D.E. Comparisonof the PspA sequence from Streptococcus pneumonia EF5668 to previously identifiedPspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protectionagainst Pneumococci of different capsular types. Infection and Immunity 1998;10:4748-4754.
24. Vig, P.J.S., McDaniel, D.O., Subramony, S.H., Qin, Z. The effects of calbindinD-28k and parvalbumin antisense oligonucleotides on the survival of culturedPurkinje cells. Research Communications in Molecular Pathology and Pharmacology1999, 103:249-259.
25. Subramony, S.H., McDaniel, D.O., Smith, S., Vig, P.J.S. SpinocerebellarAtaxia Type 3. Gene Clinics 1999; 1-10.
26. Subramony, S.H., Vig, P.J.S., McDaniel, D.O. Dominantly inherited ataxias.Archives of Neurology 2000; 19:419-426.
27. McDaniel, D.O., Nguyen, McDaniel, S.L. A new HLA-DPA1allele, DPA1*02016identified in African-American population. Tissue Antigen. 2000; 55:197-198.
28. Vig, P.J.S., Subramony, S.H., Qin, Z., McDaniel, D.O., Fratkin, J.D. Relationshipbetween ataxin-1 nuclear inclusions and Purkinje cell specific proteins inSCA-1 transgenic mice. J Neurological Sciences 2000; 174:100-110.
29. McDaniel, D.O., Keats, B.J., Vedanarayanan, V.V. Subramony, S.H. SequenceVariation in GAA repeat expansions may cause differential phenotype displayin Friedreich’s Ataxia. Movement Disorders 2001; 16: 1153-1158.
30. Reno, W.L., McDaniel, D.O., Turner, W.W., William, M.D. Polymerase chainreaction for the detection of bacteremia. American Surgeon 2001; 67:508-512.
31. Bosarge, J.R., Watt, J.M., McDaniel, D.O., Swiatlo, E., McDaniel, L.S.Genetic immunization with the region encoding the -Helical domainof PspA elicits protective immunity against Streptococcus pneumonia. InfectionImmunity 2001; 69:5456-5463.
32. Vig, P.J.S., Subramony, S.H., McDaniel, D.O. Calcium homeostasis and spinocerebellarataxia-1 (SCA-1). Brain Research Bulletin 2001; 56: 221-225.
33. Subramony, S.H., Hernandez, D., Adam, A., Smith-Jefferson, S., Hussey,J., Gwinn-Hardy, K., Lynch, T., McDaniel, D. O., Hardy, J., Farrer, M., Singleton,A. Ethnic differences in the expression of neurodegenerative disease: Machado-Josephdisease in Africans and Caucasians. Movement Disorders 2002; 17: 1068-1071.
34. McDaniel, D.O. DNA transfer approaches in treatment of chronic inflammatoryjoint disease. J Long Term Effects Medical Implants 2002; 12: 71-84.
35. McDaniel, D.O. Modulation of immunosuppression by DNA transfer in Transplantation.J Long Term Effects Medical Implants 2002; 12: 131-147.
36. Rogers, P.D., Thornton, J., Barker, K.S., McDaniel, D.O., Sacks, G.S.,Swiatlo, E., McDaniel, L.S. Pneumolysin-dependent and independent gene expressionidentified by cDNA microarray analysis in THP-1 human mononuclear cells stimulatedby Streptococcus pneumoniae. Infection Immunity 2003; 71:-2087-2094.
37. Miller S.O., Ewing, G.P., Howard, C., Tachikawa, H., Bigler, S.T., Barber,W.H., Angel, M., McDaniel, D.O. Incorporating cytochrome P450 3A4 genotypeexpression and FT-IR/Raman spectroscopy data as means of identification ofbreast tumors. Biomedical Sciences Instrumentation. 2003; 39: 24-29.
38. McDaniel, D.O., Barber, W.H., Nguyan, C., Rhodes, S.W., May, W.L., McDaniel,L.S., Jemeson, L.L., Butkus, D.E. Combined analysis of cytokine genotype polymorphismand the level of expression with allograft function in African-American renaltransplantation patients. Transplant Immunol 2003; 11: 107-119.
39. Howard, C.B., Stevens, J., Izevigie, E.B., Walker, A., McDaniel, D.O.Time and dose-dependent modulation of phase 1 and phase 2 gene expressionin response to treatment of MCF-7 cells with a natural anti-cancer agent.Cellular and Molecular Biology. 2003; 49 (7): 1057-1065.
40. McDaniel, D.O., Roten, D.P., Moore, C.K., Coleman, V., Yamout, S., Chatham,T.F., Turner, W.W.,Jr. Cytokine gene polymorphism may predict rejection incardiac transplantation patients. J. Applied Research, 2004; 4(1):68-80.
41. McDaniel, L.S., Thornton, J., McDaniel, D.O. Use of cDNA microarragysto analyze pneumococcal virulence factors. Indian J Med Res, 2004; 199 :99-103.
42. McDaniel, D.O., Yamout, S, Aru, G., May W, Thornton, J, Alam, N., MooreC. Cytokine genes associated with CV following transplantation. InternationalProceedings of Immunology, 2004; 493-499.
43. Harrison, S., Mangilog, B.A., Zhou, X., Barber, W.H., Barker, A., Doolittle,J., Godfrey, L. McDaniel, D. O. Analysis of CYP 3A4 genotype variation inrenal transplant recipients. Human Immunol, 2004; 65: (supplement 1), 38.
44. Arrington, D.T., Mangilog, B.D., Tee, L.Y., Harrison, D., Zhou, X., McDaniel,D.O. Ethnicity influences the distribution of cytochrome P450 3A4 gene polymorphism.J MAS 2005, 50:129-137.
45. Zhou, X., Barber, W.H., Moore, C., Tee, L.Y., Aru, G., Harrison, S., Mangillog,B., McDaniel, D.O. Frequency distribution of Cytochrome P450 3A4 gene polymorphismin ethnic populations and in transplant recipients. Res Comm Mole Path Pharma.2005, XX:XXX-XXX.
45. Sud, V., Lindley, S.G., McDaniel, D.O., Freeland, A.E., Zhang, F., Dorsett-Martin,W., Bigler, S.A., Lineaweaver, W. Evaluation of Fructose 1,6 diphosphate forsalvage of ischemic gracilis flaps in rats. J Reconstructive Microsurgery.2005; 3: 191-196.
1. Murphy, J.W., McDaniel, D.O. In vitro reactivity of natural killer (NK)cells against Cryptococcus neoformans. J. Immunol. 1982; 128(4):1577-1583.
2. McDaniel, D.O., Reveille, J.D. , Barger, B.O., Acton, R.T. Associationof restriction fragment length polymorphism with seronegative spondyloarthropathies.Biochemical Transactions 1985; 14:85-86.
3. Acton, R.T., Hodge, T.W., McDaniel, D.O., Reveille, J.D. Napier-Littrell,M., and Barger, B.O. HLA restriction fragment length polymorphisms associatedwith Insulin dependent diabetes mellitus and the seronegative spondyloarthropathies.Bioscience Reports. 1985; 5:815-829.
4. McDaniel, D.O., Acton R.T., Barger, B.O., Koopman, W.J., and Reveille,J.D. Association of a 9.2 Kb PvuII MHC Class I restriction length polymorphismwith ankylosing spondylitis. Arthritis Rheum. 1987; 30:894-900.
5. Napier-Littrell, M., Acton, R.T., McDaniel, D.O., Hodge, T.W. and Barger,B.O. Association of restriction fragment length polymorphisms with MHC ClassII phenotypes in white and black individuals. Transplantation Proc. 1987;19(1):826-832.
6. Acton, R.T., Barger, B.O., Brennan, J., Chandler, J., Cousins, L., Go,R., Gore, T., McDaniel, D.O., Moore, P., Olsen, G., Simpson, M., Vanichanan,C., Wagenkenecht, L., and Copeland, R. Immunogenetic and genetic risk indicationsof early-onset coronary heart disease. Federation Proc 1988; 47:1652
7. McDaniel, D.O., Barger, B.O.,., Koopman, W.J., Acton R.T., and Alarcón,G.S. Molecular genetic studies of rheumatoid arthritis. Amer J Med 1988; 85:23-25.
8. Reveille, J.D., Koopman, W.J., Barger, B.O., Acton, R.T. and McDaneil,D.O. Restriction fragment length polymorphism analysis in ankylosing spondylitis.Amer J Med 1988; 85:48-50.
9. McDaniel, D.O., Barger, B.O.,., Koopman, W.J., Acton R.T., and Reveille,J.D. AS and a 9.2 Kb PvuII Class I HLA DNA restriction fragment . J Rheumatol.1989; 14:145-146.
10. Acton, R.T., Hodge, T.W., Go, R.C.P., Peiper, S.C., Barger, B.O., Harman,L., and McDaniel, D.O. A stratified approach to forensic identification byDNA analysis of genes within the major histocompatibility complex (MHC). FBIPublications, 1989.
11. McDaniel, D.O., Acton R.T., Barger, B.O., Koopman, W.J., and Alarcón,G.S. Molecular analysis of HLA-D region genes in seropositive rheumatoid arthritis.Tissue Antigens 1989; 34:299-308.
12. Yang, P.M., Crowley, J.J., McDaneil, D.O., Koopman, W.J., Kozin, F., Carson,D.A., and Chen, P.P. Genetic studies of four highly homologous rheumatoidfactor-associated Vk genes, in rheumatoid arthritis patients and normal individuals.Mol Immunol 1991; 28(10):1073-1083.
13. Perry, R., Go, R.C.P., Harrell, L., McDaniel, D.O., Vanichanan, C., Foster,L.J., and Acton, R.T. PCR-RFLP and SSCP analyses of the APP and PRNP genesin early-onset of Alzheimer disease patients. Proceedings of The GreenwoodCenter 1992; Vol 11:178.
14. McDaniel, D.O., Naftilan, J., Barber W.H. Limiting detection of an amplificationsignal for HLA-D region and VNTR genes by 32P-PCR. Biotechniques. 1993; 15:140-145.
15. McDaniel, D.O., Naftilan. J., Hulvey, K., Shaneyfelt, D., Lemons J.A.,Lagoo-Deenadayalan, S., Hudson, S., Diethelm, A.G., Barber, W.H. Peripheralblood chimerism in renal allograft recipients transfused with donor bone marrow.Transplantation. 1994; 57:852-856.
16. Reveille, J.D., Suarez-Almazor, M.E., Russell, A.S., Go, R.C.P., Appleyard,J., Barger, B.O., Acton, R.T., Koopman, W.J., McDaniel, D.O. HLA in Ankylosingspondylitis. Is HLA-B27 the only MHC gene involved in disease pathogenesis.Sem Arthritis Rheum, 1994; 295-309.
17. McDaniel, L.S., Ralph, B.A., McDaniel, D.O., Briles, D.E. Localizationof protection eliciting epitopes on PspA of Streptococcus pneumoniae betweenamino acid residues 192 and 260. Microbial Pathogenesis. 1994; 17:323-337.
18. Lagoo-Deenadayalan, S., Lagoo, A.S., Lemons, J.A., Lorenz, H.M., McDaniel,D.O., Hardy, K.J., Barber, W.H. Donor specific bone marrow cells suppresslymphocyte reactivity to donor antigens and differentially modulate Th1 andTh2 cytokine gene expression in the responder cell population. TransplantImmunology, 1995; 3:108-118.
19. McDaniel, D.O., Alarcón, G.S., Pratt, P.W., Reveille, J.D. Most African-AmericanPatients with Rheumatoid Arthritis do not have the Rheumatoid Antigenic determinant(Epitope). Ann Intern Med. 1995; 123:181-187.
20. Lagoo-Deenadayalan, S., Lagoo, A.S., Lemons, J.A., Lorenz, H.M., McDaniel,D.O., Hardy, K.J., Barber, W.H. Donor specific bone marrow cells suppresslymphocyte reactivity to donor antigens and differentially modulate Th1 andTh2 cytokine gene expression in the responder cell population. Advances inNephrology. 1996; 25:107-127.
21. Salhudeen, A., Wang, C., McDaniel, D.O., Lagoo, S.D., Bigler, S., Barber,W.H. Antioxidant Lazaroid U-74006F improves renal function and reduces theexpression of cytokines, iNOS, and MHC antigens in a syngeneic renal transplantmodel. Transplantaiton 1996; 62:1628-1633.
22. Vig, P.J.S., Subramony, S.H., Burright, E.N., Fratkin, J.D., McDaniel,D.O., Desaia, D., Qin, Z. Reduced immunoreactivity to Ca binding proteinsin Purkinje cells proceeds onset of ataxia in spinocerebellar ataxia 1 (SCA-1)transgenic mice. Neurology, 1998; 50:106-113.
23. McDaniel, L.S., McDaniel, D.O., Hollingshead, S.K., Briles, D.E. Comparisonof the PspA sequence from Streptococcus pneumonia EF5668 to previously identifiedPspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protectionagainst Pneumococci of different capsular types. Infection and Immunity 1998;10:4748-4754.
24. Vig, P.J.S., McDaniel, D.O., Subramony, S.H., Qin, Z. The effects of calbindinD-28k and parvalbumin antisense oligonucleotides on the survival of culturedPurkinje cells. Research Communications in Molecular Pathology and Pharmacology1999, 103:249-259.
25. Subramony, S.H., McDaniel, D.O., Smith, S., Vig, P.J.S. SpinocerebellarAtaxia Type 3. Gene Clinics 1999; 1-10.
26. Subramony, S.H., Vig, P.J.S., McDaniel, D.O. Dominantly inherited ataxias.Archives of Neurology 2000; 19:419-426.
27. McDaniel, D.O., Nguyen, McDaniel, S.L. A new HLA-DPA1allele, DPA1*02016identified in African-American population. Tissue Antigen. 2000; 55:197-198.
28. Vig, P.J.S., Subramony, S.H., Qin, Z., McDaniel, D.O., Fratkin, J.D. Relationshipbetween ataxin-1 nuclear inclusions and Purkinje cell specific proteins inSCA-1 transgenic mice. J Neurological Sciences 2000; 174:100-110.
29. McDaniel, D.O., Keats, B.J., Vedanarayanan, V.V. Subramony, S.H. SequenceVariation in GAA repeat expansions may cause differential phenotype displayin Friedreich’s Ataxia. Movement Disorders 2001; 16: 1153-1158.
30. Reno, W.L., McDaniel, D.O., Turner, W.W., William, M.D. Polymerase chainreaction for the detection of bacteremia. American Surgeon 2001; 67:508-512.
31. Bosarge, J.R., Watt, J.M., McDaniel, D.O., Swiatlo, E., McDaniel, L.S.Genetic immunization with the region encoding the -Helical domainof PspA elicits protective immunity against Streptococcus pneumonia. InfectionImmunity 2001; 69:5456-5463.
32. Vig, P.J.S., Subramony, S.H., McDaniel, D.O. Calcium homeostasis and spinocerebellarataxia-1 (SCA-1). Brain Research Bulletin 2001; 56: 221-225.
33. Subramony, S.H., Hernandez, D., Adam, A., Smith-Jefferson, S., Hussey,J., Gwinn-Hardy, K., Lynch, T., McDaniel, D. O., Hardy, J., Farrer, M., Singleton,A. Ethnic differences in the expression of neurodegenerative disease: Machado-Josephdisease in Africans and Caucasians. Movement Disorders 2002; 17: 1068-1071.
34. McDaniel, D.O. DNA transfer approaches in treatment of chronic inflammatoryjoint disease. J Long Term Effects Medical Implants 2002; 12: 71-84.
35. McDaniel, D.O. Modulation of immunosuppression by DNA transfer in Transplantation.J Long Term Effects Medical Implants 2002; 12: 131-147.
36. Rogers, P.D., Thornton, J., Barker, K.S., McDaniel, D.O., Sacks, G.S.,Swiatlo, E., McDaniel, L.S. Pneumolysin-dependent and independent gene expressionidentified by cDNA microarray analysis in THP-1 human mononuclear cells stimulatedby Streptococcus pneumoniae. Infection Immunity 2003; 71:-2087-2094.
37. Miller S.O., Ewing, G.P., Howard, C., Tachikawa, H., Bigler, S.T., Barber,W.H., Angel, M., McDaniel, D.O. Incorporating cytochrome P450 3A4 genotypeexpression and FT-IR/Raman spectroscopy data as means of identification ofbreast tumors. Biomedical Sciences Instrumentation. 2003; 39: 24-29.
38. McDaniel, D.O., Barber, W.H., Nguyan, C., Rhodes, S.W., May, W.L., McDaniel,L.S., Jemeson, L.L., Butkus, D.E. Combined analysis of cytokine genotype polymorphismand the level of expression with allograft function in African-American renaltransplantation patients. Transplant Immunol 2003; 11: 107-119.
39. Howard, C.B., Stevens, J., Izevigie, E.B., Walker, A., McDaniel, D.O.Time and dose-dependent modulation of phase 1 and phase 2 gene expressionin response to treatment of MCF-7 cells with a natural anti-cancer agent.Cellular and Molecular Biology. 2003; 49 (7): 1057-1065.
40. McDaniel, D.O., Roten, D.P., Moore, C.K., Coleman, V., Yamout, S., Chatham,T.F., Turner, W.W.,Jr. Cytokine gene polymorphism may predict rejection incardiac transplantation patients. J. Applied Research, 2004; 4(1):68-80.
41. McDaniel, L.S., Thornton, J., McDaniel, D.O. Use of cDNA microarragysto analyze pneumococcal virulence factors. Indian J Med Res, 2004; 199 :99-103.
42. McDaniel, D.O., Yamout, S, Aru, G., May W, Thornton, J, Alam, N., MooreC. Cytokine genes associated with CV following transplantation. InternationalProceedings of Immunology, 2004; 493-499.
43. Harrison, S., Mangilog, B.A., Zhou, X., Barber, W.H., Barker, A., Doolittle,J., Godfrey, L. McDaniel, D. O. Analysis of CYP 3A4 genotype variation inrenal transplant recipients. Human Immunol, 2004; 65: (supplement 1), 38.
44. Arrington, D.T., Mangilog, B.D., Tee, L.Y., Harrison, D., Zhou, X., McDaniel,D.O. Ethnicity influences the distribution of cytochrome P450 3A4 gene polymorphism.J MAS 2005, 50:129-137.
45. Zhou, X., Barber, W.H., Moore, C., Tee, L.Y., Aru, G., Harrison, S., Mangillog,B., McDaniel, D.O. Frequency distribution of Cytochrome P450 3A4 gene polymorphismin ethnic populations and in transplant recipients. Res Comm Mole Path Pharma.2005, XX:XXX-XXX.
45. Sud, V., Lindley, S.G., McDaniel, D.O., Freeland, A.E., Zhang, F., Dorsett-Martin,W., Bigler, S.A., Lineaweaver, W. Evaluation of Fructose 1,6 diphosphate forsalvage of ischemic gracilis flaps in rats. J Reconstructive Microsurgery.2005; 3: 191-196.